Tyrosyl-tRNA sequestration triggers tyrosyl-tRNA synthetase-associated peripheral neuropathy
Abstract
Mono-allelic mutations in seven cytosolic aminoacyl-tRNA synthetase genes cause Charcot–Marie–Tooth (CMT) peripheral neuropathy.
Here, we report that tyrosyl-tRNA (tRNATyr) sequestration by CMT-mutant tyrosyl-tRNA synthetase (TyrRS) is the molecular root cause of CMT-YARS1. tRNATyr sequestration depletes the cellular free tRNATyr pool, leading to insufficient tyrosyl-tRNATyr production and ribosome stalling at tyrosine codons.
In three Drosophila CMT-YARS1 models, transgenic overexpression of tRNATyr rescued peripheral neuropathy phenotypes and defective mRNA translation. We provide biochemical evidence for tRNATyr sequestration by the three CMT-TyrRS variants expressed in the Drosophila models and ribosome profiling revealed selective ribosome pausing at the two tyrosine codons. In the Yars1E196K mouse model, adeno-associated virus serotype 9 (AAV9)-mediated overexpression of tRNATyr—but not wild-type TyrRS protein—fully rescued motor performance deficits, reduced nerve conduction velocity and reduced motor axon calibre. Furthermore, AAV9-tRNATyr gene therapy prevented activation of the integrated stress response in spinal motor neurons, indicating resolution of ribosome stalling.
Thus, elevating tRNATyr levels constitutes a novel therapeutic approach for CMT-YARS1.
Related
- Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy
- Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model
- Biallelic PIGB Variants Cause Motor Neuropathy with Conduction Blocks and Peripheral Nerve Hyperexcitability
- Elevated cortical tension triggers precocious ectopic polarization in mammalian oocytes, associated with lower developmental potential.
- DNA damage at Lamina-Associated Domains triggers nuclear envelope reorganization and chromatin detachment to prevent nuclear envelope blebbing and genome instability.
BibTeX
@article{mallik2026tyrosyltrna,
title = {{Tyrosyl-tRNA sequestration triggers tyrosyl-tRNA synthetase-associated peripheral neuropathy}},
author = {Moushami Mallik and Abigail L D Tadenev and Natalia Mora and Vanessa Lewandowski and Daniel Köster and María Landínez-Macías and Robin Thompson and María P Menafra and Noah K Taylor and Pascal van Lith and Nick van Bakel and Marica Catinozzi and Scott Q Harper and Zoya Ignatova and Robert W Burgess and Erik Storkebaum},
journal = {Brain},
year = {2026},
month = aug,
doi = {10.1093/brain/awag204},
url = {https://doi.org/10.1093/brain/awag204},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Tyrosyl-tRNA sequestration triggers tyrosyl-tRNA synthetase-associated peripheral neuropathy
AU - Moushami Mallik
AU - Abigail L D Tadenev
AU - Natalia Mora
AU - Vanessa Lewandowski
AU - Daniel Köster
AU - María Landínez-Macías
AU - Robin Thompson
AU - María P Menafra
AU - Noah K Taylor
AU - Pascal van Lith
AU - Nick van Bakel
AU - Marica Catinozzi
AU - Scott Q Harper
AU - Zoya Ignatova
AU - Robert W Burgess
AU - Erik Storkebaum
PY - 2026
DA - 2026/08/12
JO - Brain
DO - 10.1093/brain/awag204
UR - https://doi.org/10.1093/brain/awag204
AB - Mono-allelic mutations in seven cytosolic aminoacyl-tRNA synthetase genes cause Charcot–Marie–Tooth (CMT) peripheral neuropathy. Here, we report that tyrosyl-tRNA (tRNATyr) sequestration by CMT-mutant tyrosyl-tRNA synthetase (TyrRS) is the molecular root cause of CMT-YARS1. tRNATyr sequestration depletes the cellular free tRNATyr pool, leading to insufficient tyrosyl-tRNATyr production and ribosome stalling at tyrosine codons. In three Drosophila CMT-YARS1 models, transgenic overexpression of tRNATyr rescued peripheral neuropathy phenotypes and defective mRNA translation. We provide biochemical evidence for tRNATyr sequestration by the three CMT-TyrRS variants expressed in the Drosophila models and ribosome profiling revealed selective ribosome pausing at the two tyrosine codons. In the Yars1E196K mouse model, adeno-associated virus serotype 9 (AAV9)-mediated overexpression of tRNATyr—but not wild-type TyrRS protein—fully rescued motor performance deficits, reduced nerve conduction velocity and reduced motor axon calibre. Furthermore, AAV9-tRNATyr gene therapy prevented activation of the integrated stress response in spinal motor neurons, indicating resolution of ribosome stalling. Thus, elevating tRNATyr levels constitutes a novel therapeutic approach for CMT-YARS1.
SN - 0006-8950
SN - 1460-2156
ER -